{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:28:03Z","timestamp":1793302083570,"version":"4.5.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To clarify the causal relationship between anxiety-depression and the progression and outcomes of vitiligo, providing a basis for enhancing psychological interventions in the treatment of vitiligo.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A two-sample Mendelian randomization analysis was used to validate the causal relationship between anxiety, depression, and vitiligo. The Hospital Anxiety and Depression Scale (HADS) assessed the psychiatric condition of vitiligo patients. Fisher\u2019s chi-square tests and rank sum tests analyzed the differences in clinical characteristics among vitiligo patients with different HADS scores. Regression analysis assessed the correlation between anxiety-depression and disease progression and treatment outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mendelian randomization analysis showed that depression significantly increases the risk of vitiligo (OR\u2009=\u20094.46, 95% CI: 1.16\u201317.18, <jats:italic>p<\/jats:italic>\u2009=\u20090.03). According to the HADS scores, clinical characteristics differed significantly among the groups (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). Univariate regression analysis demonstrated that both HADS (<jats:italic>B<\/jats:italic>\u2009=\u2009\u20131.168, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001, 95% CI: \u22121.532 to \u22120.804) and VIDA (<jats:italic>B<\/jats:italic>\u2009=\u2009\u20132.157, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001, 95% CI: \u22123.464 to \u22120.887) were significantly negative associated factors for disease outcomes. However, HADS (<jats:italic>B<\/jats:italic>\u2009=\u2009\u20131.006, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.001, 95% CI: \u22121.475 to \u22120.657) emerged as the only factor influencing therapeutic efficacy in multivariate regression analysis. A restricted cubic spline graph illustrates a U-shaped relationship between HADS and clinical efficacy, with the most significant impact on therapeutic efficacy occurring when HADS equals 15.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Anxiety\u2014depression exhibit a bidirectional positive causal relationship with vitiligo. Moderate to severe anxiety-depression significantly influences the clinical efficacy of vitiligo treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpsyg.2024.1454947","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:31:17Z","timestamp":1726806677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Anxiety\u2014depression: a pivotal mental factor for accelerating disease progression and reducing curative effect in vitiligo patients"],"prefix":"10.3389","volume":"15","author":[{"given":"Cheng","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoni","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,9,20]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"797026","DOI":"10.3389\/fcell.2021.797026","article-title":"Vitiligo: an autoimmune skin disease and its immunomodulatory therapeutic intervention","volume":"9","author":"Chang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2174\/1871528113666140522104422","article-title":"Brain-skin connection: stress, inflammation and skin aging","volume":"13","author":"Chen","year":"2014","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","article-title":"Psychosocial effects of vitiligo: a systematic literature review","volume":"22","author":"Ezzedine","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/sj.jid.5700151","article-title":"Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance","volume":"126","author":"Grando","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1365-2133.1977.tb15180.X","article-title":"Vitiligo: a new classification and treatment approach","volume":"97","author":"Koga","year":"1997","journal-title":"Chinese Journal of Dermatology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e0271719","DOI":"10.1371\/journal.pone.0271719","article-title":"Gene polymorphisms and serum levels of BDNF and CRH in vitiligo patients","volume":"17","author":"Kussainova","year":"2022","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the pathogenesis of vitiligo","volume":"97","author":"Marchioro","year":"2022","journal-title":"An. Bras. Dermatol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijms23020669","article-title":"The brain-skin Axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects","volume":"23","author":"Marek-Jozefowicz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000073036","article-title":"Prescribing cyclic antidepressants for vitiligo patients: which agents are superior, which are not?","volume":"72","author":"Namazi","year":"2003","journal-title":"Psychother. Psychosom."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/PRBM.S370445","article-title":"Evaluation of the behavioral and psychological symptoms in patients with vitiligo in China","volume":"15","author":"Ning","year":"2022","journal-title":"Psychol. Res. Behav. Manag."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/bjd.16049","article-title":"The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis","volume":"178","author":"Osinubi","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"e98283","DOI":"10.1371\/journal.pone.0098283","article-title":"Chronic stress suppresses the expression of cutaneous hypothalamic-pituitary-adrenocortical axis elements and melanogenesis","volume":"9","author":"Pang","year":"2014","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1365-2230.1998.00384.x","article-title":"Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology","volume":"23","author":"Papadopoulos","year":"1998","journal-title":"Clin. Exp. Dermatol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40257-017-0279-8","article-title":"Psoriasis, depression, and inflammatory overlap: a review","volume":"18","author":"Patel","year":"2017","journal-title":"Am. J. Clin. Dermatol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000069731","article-title":"Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study","volume":"72","author":"Picardi","year":"2003","journal-title":"Psychother Psychosom."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1600-0625.2010.01239.x","article-title":"Stress-induced epinephrine levels compromise murine dermal fibroblast activity through-adrenoceptors","volume":"20","author":"Romana-Souza","year":"2011","journal-title":"Exp. Dermatol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"e13418","DOI":"10.1111\/dth.13418","article-title":"Psychodermatology of vitiligo: psychological impact and consequences","volume":"33","author":"Simons","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00403-022-02333-3","article-title":"Catecholamines' accumulation and their disturbed metabolism at perilesional site: a possible cause of vitiligo progression","volume":"315","author":"Tanwar","year":"2023","journal-title":"Arch. Dermatol. Res."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.rcp.2017.07.002","article-title":"Psychodermatology: an association of primary psychiatric disorders with skin","volume":"48","author":"Tohid","year":"2019","journal-title":"Rev Colomb Psiquiatr"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e0243357","DOI":"10.1371\/journal.pone.0243357","article-title":"The hospital anxiety and depression scale (HADS) applied to Ethiopian cancer patients","volume":"15","author":"Wondie","year":"2020","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ajhg.2022.04.001","article-title":"Combining evidence from Mendelian randomization and colocalization: review and comparison of approaches","volume":"109","author":"Zuber","year":"2022","journal-title":"Am. J. Hum. Genet."}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2024.1454947\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T04:31:19Z","timestamp":1726806679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2024.1454947\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,20]]},"references-count":21,"alternative-id":["10.3389\/fpsyg.2024.1454947"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2024.1454947","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,20]]},"article-number":"1454947"}}